Researchers from Merlin project partner Erasmus MC recently made a number of presentations at the Dutch Transplantation Society Meeting held on 9 and 10 March 2016 in Groningen. These included a poster presentation about the Merlin project entitled “Optimizing the immunogenicity and immunomodulatory properties of MSC “, (S.F.H. de Witte et al). For more details see here.
- Advancing Therapies | This report highlights the acceleration of cell and gene therapy approvals worldwide t.co/4xSTJvD7ha Time ago 17 Days via Twitter Web Client
- RT @PintailLimited: PROJECT HIGHLIGHT: @VISICORT PI Prof John Armitage, of University of Bristol awarded an OBE in the Queen’s New Year Ho… Time ago 21 Days via Twitter Web Client
- Our @FP7Merlin partners @Orbsen Therapeutics are hiring a Senior #GMP Production Scientist for production in… t.co/SLsfNK61iW Time ago 21 Days via Twitter Web Client
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.